CMB increases its holdings in Sino Biopharmaceutical Limited (01801.HK) by around 1,438,800 shares, with an estimated price of around HK$84.73 per share.

According to the latest information from the Securities Times app, Hong Kong Stock Exchange data shows that on November 11, Morgan Stanley increased its holdings of Xinda Biotechnology (01801.HK) by 1,438,757 shares, with a price of 84.7327 Hong Kong dollars per share, totaling about 122 million Hong Kong dollars. After the increase, the latest number of shares held is approximately 86.8411 million shares, and the latest shareholding ratio is 5.06%.